Education
About Us
Working with TipRanks
Follow Us
Genetic Technologies Limited (AU:GTG)
:GTG
GTG Stock Chart & Stats
AU$0.04
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$0.04
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.04 - AU$0.04
Previous CloseN/A
Volume10.07K
Average Volume (3M)0.00
Market Cap
AU$5.67M
Enterprise ValueN/A
Total Cash (Recent Filing)AU$1.02M
Total Debt (Recent Filing)AU$875.19K
Price to Earnings (P/E)―
Beta1.31
Next Earnings
Feb 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,335,422,500
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Genetic Technologies News
GTG FAQ
What was Genetic Technologies Limited’s price range in the past 12 months?
Genetic Technologies Limited lowest share price was AU$0.04 and its highest was AU$0.04 in the past 12 months.
What is Genetic Technologies Limited’s market cap?
Genetic Technologies Limited’s market cap is AU$5.67M.
When is Genetic Technologies Limited’s upcoming earnings report date?
Genetic Technologies Limited’s upcoming earnings report date is Feb 20, 2026 which is in 112 days.
How were Genetic Technologies Limited’s earnings last quarter?
Currently, no data Available
Is Genetic Technologies Limited overvalued?
According to Wall Street analysts Genetic Technologies Limited’s price is currently Overvalued.
Does Genetic Technologies Limited pay dividends?
Genetic Technologies Limited does not currently pay dividends.
What is Genetic Technologies Limited’s EPS estimate?
Genetic Technologies Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genetic Technologies Limited have?
Genetic Technologies Limited has 1,335,422,500 shares outstanding.
What happened to Genetic Technologies Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Genetic Technologies Limited?
Currently, no hedge funds are holding shares in AU:GTG
Company Description
Genetic Technologies Limited
Genetic Technologies Limited (GTG) is a molecular diagnostics company specializing in the development and commercialization of genetic risk assessment tests. The company operates primarily in the biotechnology sector, focusing on predictive genetic testing and risk assessment tools. GTG's core services include offering genetic tests that help in identifying an individual's susceptibility to various health conditions, enabling personalized healthcare and proactive patient management.
Technical Analysis
BCAL Diagnostics Limited
―
Rhythm Biosciences Ltd.
―
Lumos Diagnostics Holdings Ltd.
―
Imagion Biosystems Ltd.
―
Inoviq Ltd
―